TBC1D8B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.561600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.915000E-01
Normal-vs-Stage2
2.274800E-01
Normal-vs-Stage3
7.579800E-01
Normal-vs-Stage4
6.661900E-02
Stage1-vs-Stage2
7.343200E-01
Stage1-vs-Stage3
3.002000E-01
Stage1-vs-Stage4
2.420800E-01
Stage2-vs-Stage3
3.116200E-01
Stage2-vs-Stage4
6.180300E-02
Stage3-vs-Stage4
3.047800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.831600E-01
Normal-vs-AfricanAmerican
2.280800E-01
Normal-vs-Asian
3.311600E-01
Caucasian-vs-AfricanAmerican
5.184000E-01
Caucasian-vs-Asian
8.988800E-01
AfricanAmerican-vs-Asian
6.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.594600E-01
Normal-vs-Female
2.663600E-01
Male-vs-Female
8.524600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.978400E-01
Normal-vs-Age(41-60Yrs)
1.380180E-01
Normal-vs-Age(61-80Yrs)
3.147200E-01
Normal-vs-Age(81-100Yrs)
6.316400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.175000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.636400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.628800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.337700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.805600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.537200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.490200E-01
Normal-vs-Daily Drinker
6.933400E-01
Normal-vs-Weekly Drinker
3.631200E-01
Normal-vs-Occasional Drinker
1.508550E-01
Normal-vs-Social Drinker
1.954380E-01
Non Drinker-vs-Daily Drinker
3.486800E-01
Non Drinker-vs-Weekly Drinker
9.468200E-01
Non Drinker-vs-Occasional Drinker
4.783700E-02
Non Drinker-vs-Social Drinker
7.891500E-02
Daily Drinker-vs-Weekly Drinker
4.197600E-01
Daily Drinker-vs-Occasional Drinker
1.939790E-02
Daily Drinker-vs-Social Drinker
3.565900E-02
Weekly Drinker-vs-Occasional Drinker
1.285180E-01
Weekly Drinker-vs-Social Drinker
1.775010E-01
Occasional Drinker-vs-Social Drinker
9.555200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.791770E-01
Normal-vs-Grade 2
2.716500E-02
Normal-vs-Grade 3
4.361800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.394000E-02
Grade 1-vs-Grade 3
1.256440E-01
Grade 1-vs-Grade 4
1.791770E-01
Grade 2-vs-Grade 3
9.490200E-01
Grade 2-vs-Grade 4
2.716500E-02
Grade 3-vs-Grade 4
4.361800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.238600E-01
Normal-vs-NonDiabetic
2.976800E-01
Diabetic-vs-NonDiabetic
4.518400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.681600E-01
Normal-vs-NoPancreatitis
3.135800E-01
Pancreatitis-vs-NoPancreatitis
8.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.264200E-01
Normal-vs-N1
2.187000E-01
N0-vs-N1
9.979400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.885220E-01
Normal-vs-TP53-NonMutant
2.297000E-01
TP53-Mutant-vs-TP53-NonMutant
3.907400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
